Net profit of Alivus Life Sciences rose 44.85% to Rs 141.87 crore in the quarter ended March 2025 as against Rs 97.94 crore during the previous quarter ended March 2024. Sales rose 21.05% to Rs 649.55 crore in the quarter ended March 2025 as against Rs 536.60 crore during the previous quarter ended March 2024.
For the full year,net profit rose 3.13% to Rs 485.63 crore in the year ended March 2025 as against Rs 470.89 crore during the previous year ended March 2024. Sales rose 4.54% to Rs 2386.88 crore in the year ended March 2025 as against Rs 2283.21 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 649.55 | 536.60 | 21 | 2386.88 | 2283.21 | 5 |
| OPM % | 30.55 | 26.36 | - | 28.60 | 29.53 | - |
| PBDT | 207.27 | 144.21 | 44 | 714.74 | 684.74 | 4 |
| PBT | 191.30 | 129.68 | 48 | 654.13 | 631.29 | 4 |
| NP | 141.87 | 97.94 | 45 | 485.63 | 470.89 | 3 |